Pernicious anemia and Vitamin B 12 deficiency anemia (DC 7722) | VA Rating Tool
| Diagnostic Code | 7722 |
|---|---|
| Category | The Hemic and Lymphatic Systems |
| Subcategory | The Hematologic and Lymphatic Systems |
| Also Known As | Pernicious anemia and Vitamin B 12 deficiency anemia |
| CFR Section | 4.117 |
Next Steps for This Condition
Rating Criteria
| Rating | Criteria |
|---|---|
| 100% | For initial diagnosis requiring transfusion due to severe anemia, or if there are signs or symptoms related to central nervous system impairment, such as encephalopathy, myelopathy, or severe peripheral neuropathy, requiring parenteral B 12 therapy |
| 100% | Note: A 100 percent evaluation for pernicious anemia and Vitamin B 12 deficiency shall be assigned as of the date of the initial diagnosis requiring transfusion due to severe anemia or parenteral B 12 therapy and shall continue with a mandatory VA examination six months following hospital discharge or cessation of parenteral B 12 therapy. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. Thereafter, evaluate at 10 percent and separately evaluate any residual effects of pernicious anemia, such as neurologic involvement causing peripheral neuropathy, myelopathy, dementia, or related gastrointestinal residuals, under the most appropriate diagnostic code |
| 10% | Requiring continuous treatment with Vitamin B 12 injections, Vitamin B 12 sublingual or high-dose oral tablets, or Vitamin B 12 nasal spray or gel |